Alternative splicing of the neurofibromatosis type I pre-mRNA

Bioscience Reports

Volumn 32, Issue 2, 2012, Pages 131-138

  Barron, Victoria A ^a   Lou, Hua ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CUG BP and ETR 3 like factor (CELF); Genetic modifier; Hu protein; Neurofibromatosis type i (NF1); T cell intracellular antigen 1 (TIA 1); T cell intracellular antigen 1 related protein (TIAR)

Indexed keywords

BINDING PROTEIN; CYTOSINE URIDINE GUANINE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; HU PROTEIN; ISOPROTEIN; LYMPHOCYTE ANTIGEN; MESSENGER RNA PRECURSOR; NEUROFIBROMIN; RAS PROTEIN; RNA BINDING PROTEIN; T CELL INTRACELLULAR ANTIGEN 1; T CELL INTRACELLULAR ANTIGEN 1 RELATED PROTEIN; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; CLINICAL FEATURE; DISEASE SEVERITY; EXON; FRAMESHIFT MUTATION; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC VARIABILITY; HUMAN; INTRACELLULAR SIGNALING; LEARNING DISORDER; NEUROFIBROMATOSIS; NEUROFIBROMATOSIS TYPE 1 GENE; NONHUMAN; PHENOTYPIC VARIATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; TRANSCRIPTION REGULATION;

ALTERNATIVE SPLICING; ANIMALS; GENES, NEUROFIBROMATOSIS 1; HUMANS; NEUROFIBROMATOSIS 1; NEUROFIBROMIN 1; PHENOTYPE; RNA PRECURSORS;

EID: 84856921335     PISSN: 01448463     EISSN: 15734935     Source Type: Journal    
DOI: 10.1042/BSR20110060     Document Type: Review

References (97)

1. Pan, Q., Shai, O., Lee, L. J., Frey, B. J. and Blencowe, B. J. (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet. 40, 1413-1415
2. Wang, E. T., Sandberg, R., Luo, S., Khrebtukova, I., Zhang, L., Mayr, C., Kingsmore, S. F., Schroth, G. P. and Burge, C. B. (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456, 470-476 (Pubitemid 352759009)
3. Black, D. L. (2003) Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 72, 291-336
4. Black, D. L. and Grabowski, P. J. (2003) Alternative pre-mRNA splicing and neuronal function. Prog. Mol. Subcell. Biol. 31, 187-216
5. Chen, M. and Manley, J. L. (2009) Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat. Rev. Mol. Cell Biol. 10, 741-754
6. Hui, J. (2009) Regulation of mammalian pre-mRNA splicing. Sci. China C: Life Sci. 52, 253-260
7. Nilsen, T. W. and Graveley, B. R. (2010) Expansion of the eukaryotic proteome by alternative splicing. Nature 463, 457-463
8. Li, Q., Lee, J. A. and Black, D. L. (2007) Neuronal regulation of alternative pre-mRNA splicing. Nat. Rev. Neurosci. 8, 819-831 (Pubitemid 350006218)
9. Wang, G. S. and Cooper, T. A. (2007) Splicing in disease: disruption of the splicing code and the decoding machinery. Nat. Rev. Genet. 8, 749-761
10. Garcia-Blanco, M. A., Baraniak, A. P. and Lasda, E. L. (2004) Alternative splicing in disease and therapy. Nat. Biotechnol. 22, 535-546 (Pubitemid 38585905)
11. Tazi, J., Bakkour, N. and Stamm, S. (2009) Alternative splicing and disease. Biochim. Biophys. Acta 1792, 14-26
12. Ward, A. J. and Cooper, T. A. (2009) The pathobiology of splicing. J. Pathol. 220, 152-163
13. Nissim-Rafinia, M. and Kerem, B. (2005) The splicing machinery is a genetic modifier of disease severity. Trends Genet. 21, 480-483 (Pubitemid 41132579)
14. Nissim-Rafinia, M. and Kerem, B. (2002) Splicing regulation as a potential genetic modifier. Trends Genet. 18, 123-127 (Pubitemid 34164637)
15. Nissim-Rafinia, M. and Kerem, B. (2006) Splicing modulation as a modifier of the CFTR function. Prog. Mol. Subcell. Biol. 44, 233-254
16. Salvatore, F., Scudiero, O. and Castaldo, G. (2002) Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes. Am. J. Med. Genet. 111, 88-95 (Pubitemid 34761589)
17. Evans, D. G., Howard, E., Giblin, C., Clancy, T., Spencer, H., Huson, S. M. and Lalloo, F. (2010) Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am. J. Med. Genet A 152, 327-332
18. Friedman, J. M. (1999) Epidemiology of neurofibromatosis type 1. Am. J. Med. Genet. 89, 1-6
19. Jett, K. and Friedman, J. M. (2010) Clinical and genetic aspects of neurofibromatosis 1. Genet. Med. 12, 1-11
20. Huson, S. (2008) The neurofibromatoses: classification, clinical features, and genetic counselling. Neurofibromatoses (Kaufmann, D., ed.), pp. 1-20, Karger, Basel, New York
21. Korf, B. R. (1999) Plexiform neurofibromas. Am. J. Med. Genet. 89, 31-37
22. Legius, E., Marchuk, D. A., Collins, F. S. and Glover, T. W. (1993) Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat. Genet. 3, 122-126 (Pubitemid 23079793)
23. Serra, E., Rosenbaum, T., Winner, U., Aledo, R., Ars, E., Estivill, X., Lenard, H. G. and Lazaro, C. (2000) Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations. Hum. Mol. Genet. 9, 3055-3064 (Pubitemid 32000779)
24. Messiaen, L. and Wimmer, K. (2008) NF1 mutational spectrum. In Neurofibromatoses (Kaufmann, D., ed.), pp. 63-67, Karger, Basel, New York
25. Rieley, M. B., Stevenson, D. A., Viskochil, D. H., Tinkle, B. T., Martin, L. J. and Schorry, E. K. (2011) Variable expression of neurofibromatosis 1 in monozygotic twins. Am. J. Med. Genet. A 3, 478 - 485
26. Williams, V. C., Lucas, J., Babcock, M. A., Gutmann, D. H., Korf, B. and Maria, B. L. (2009) Neurofibromatosis type 1 revisited. Pediatrics 123, 124-133
27. Ward, B. A. and Gutmann, D. H. (2005) Neurofibromatosis 1: from lab bench to clinic. Pediatr. Neurol. 32, 221-228 (Pubitemid 40410643)
28. North, K., Joy, P., Yuille, D., Cocks, N. and Hutchins, P. (1995) Cognitive function and academic performance in children with neurofibromatosis type 1. Dev. Med. Child Neurol. 37, 427-436
29. Rosser, T. L. and Packer, R. J. (2003) Neurocognitive dysfunction in children with neurofibromatosis type 1. Curr. Neurol. Neurosci. Rep. 3, 129-136 (Pubitemid 38898993)
30. Kayl, A. E. and Moore, III, B. D. (2000) Behavioral phenotype of neurofibromatosis, type 1. Ment. Retard Dev. Disabil. Res. Rev. 6, 117-124 (Pubitemid 30399534)
31. Shilyansky, C., Lee, Y. S. and Silva, A. J. (2010) Molecular and cellular mechanisms of learning disabilities: a focus on NF1. Annu. Rev. Neurosci. 33, 221-243
32. Costa, R. M. and Silva, A. J. (2002) Molecular and cellular mechanisms underlying the cognitive deficits associated with neurofibromatosis 1. J. Child Neurol. 17, 622-626 (Pubitemid 35203624)
33. Silva, A. J., Frankland, P. W., Marowitz, Z., Friedman, E., Laszlo, G. S., Cioffi, D., Jacks, T. and Bourtchuladze, R. (1997) A mouse model for the learning and memory deficits associated with neurofibromatosis type I. Nat. Genet. 15, 281-284 (Pubitemid 27098723)
34. Sabbagh, A., Pasmant, E., Laurendeau, I., Parfait, B., Barbarot, S., Guillot, B., Combemale, P., Ferkal, S., Vidaud, M., Aubourg, P. et al. (2009) Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1. Hum. Mol. Genet. 18, 2768-2778
35. Upadhyaya, M. (2008) NF1 gene structure and NF1 genotype/phenotype correlations. Neurofibromatoses (Kaufmann, D., ed.), pp. 46-62, Karger, Basel, New York
36. Viskochil, D. (1998) Gene structure and expression. In Neurofibromatosis Type 1 from Genotype to Phenotype (Upadhyaya, M. and Cooper, D. N., eds), pp. 39-56, Bios Scientific, Oxford
37. Marchuk, D. A., Saulino, A. M., Tavakkol, R., Swaroop, M., Wallace, M. R., Andersen, L. B., Mitchell, A. L., Gutmann, D. H., Boguski, M. and Collins, F. S. (1991) cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics 11, 931-940
38. Gutmann, D. H., Wood, D. L. and Collins, F. S. (1991) Identification of the neurofibromatosis type 1 gene product. Proc. Natl. Acad. Sci. U.S.A. 88, 9658-9662 (Pubitemid 21915690)
39. DeClue, J. E., Cohen, B. D. and Lowy, D. R. (1991) Identification and characterization of the neurofibromatosis type 1 protein product. Proc. Natl. Acad. Sci. U.S.A. 88, 9914-9918 (Pubitemid 21915745)
40. Daston, M. M. and Ratner, N. (1992) Neurofibromin, a predominantly neuronal GTPase activating protein in the adult, is ubiquitously expressed during development. Dev. Dyn. 195, 216-226 (Pubitemid 23119299)
41. Gutmann, D. H. (1995) Tumor suppressor genes as negative growth regulators in development and differentiation. Int. J. Dev. Biol. 39, 895-908
42. Gutmann, D. H., Zhang, Y. and Hirbe, A. (1999) Developmental regulation of a neuron-specific neurofibromatosis 1 isoform. Ann. Neurol. 46, 777-782 (Pubitemid 29518141)
43. Bernards, A., Snijders, A. J., Hannigan, G. E., Murthy, A. E. and Gusella, J. F. (1993) Mouse neurofibromatosis type 1 cDNA sequence reveals high degree of conservation of both coding and non-coding mRNA segments. Hum. Mol. Genet. 2, 645-650 (Pubitemid 23197504)
44. The, I., Hannigan, G. E., Cowley, G. S., Reginald, S., Zhong, Y., Gusella, J. F., Hariharan, I. K. and Bernards, A. (1997) Rescue of a Drosophila NF1 mutant phenotype by protein kinase A. Science 276, 791-794 (Pubitemid 27199858)
45. Lakkis, M. M., Golden, J. A., O'Shea, K. S. and Epstein, J. A. (1999) Neurofibromin deficiency in mice causes exencephaly and is a modifier for Splotch neural tube defects. Dev. Biol. 212, 80-92 (Pubitemid 29368338)
46. Welti, S., D'Angelo, I. and Scheffzek, K. (2008) Structure and function of neurofibromin. In Neurofibromatoses (Kaufmann, D., ed.), pp. 113-128, Karger, Basel, New York
47. Larizza, L., Gervasini, C., Natacci, F. and Riva, P. (2009) Developmental abnormalities and cancer predisposition in neurofibromatosis type 1. Curr. Mol. Med. 9, 634-653
48. Fahsold, R., Hoffmeyer, S., Mischung, C., Gille, C., Ehlers, C., Kucukceylan, N., Abdel-Nour, M., Gewies, A., Peters, H., Kaufmann, D. et al. (2000) Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. Am. J. Hum. Genet. 66, 790-818 (Pubitemid 30470484)
49. Gregory, P. E., Gutmann, D. H., Mitchell, A., Park, S., Boguski, M., Jacks, T., Wood, D. L., Jove, R. and Collins, F. S. (1993) Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules. Somat. Cell Mol. Genet. 19, 265-274 (Pubitemid 23216308)
50. Izawa, I., Tamaki, N. and Saya, H. (1996) Phosphorylation of neurofibromatosis type 1 gene product (neurofibromin) by cAMP-dependent protein kinase. FEBS Lett. 382, 53-59 (Pubitemid 26092233)
51. Mangoura, D., Sun, Y., Li, C., Singh, D., Gutmann, D. H., Flores, A., Ahmed, M. and Vallianatos, G. (2006) Phosphorylation of neurofibromin by PKC is a possible molecular switch in EGF receptor signaling in neural cells. Oncogene 25, 735-745 (Pubitemid 43214700)
52. Boyanapalli, M., Lahoud, O. B., Messiaen, L., Kim, B., Anderle de Sylor, M. S., Duckett, S. J., Somara, S. and Mikol, D. D. (2006) Neurofibromin binds to caveolin-1 and regulates ras, FAK, and Akt. Biochem. Biophys. Res. Commun. 340, 1200-1208 (Pubitemid 43083405)
53. Ballester, R., Marchuk, D., Boguski, M., Saulino, A., Letcher, R., Wigler, M. and Collins, F. (1990) The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 63, 851-859 (Pubitemid 120035058)
54. Xu, G. F., Lin, B., Tanaka, K., Dunn, D., Wood, D., Gesteland, R., White, R., Weiss, R. and Tamanoi, F. (1990) The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell 63, 835-841 (Pubitemid 120035056)
55. Xu, G. F., O'Connell, P., Viskochil, D., Cawthon, R., Robertson, M., Culver, M., Dunn, D., Stevens, J., Gesteland, R., White, R. et al. (1990) The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62, 599-608
56. Martin, G. A., Viskochil, D., Bollag, G., McCabe, P. C., Crosier, W. J., Haubruck, H., Conroy, L., Clark, R., O'Connell, P., Cawthon, R. M. et al. (1990) The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63, 843-849 (Pubitemid 120035057)
57. Bos, J. L. (1989) ras oncogenes in human cancer: a review. Cancer Res. 49, 4682-4689
58. D'Angelo, I., Welti, S., Bonneau, F. and Scheffzek, K. (2006) A novel bipartite phospholipid-binding module in the neurofibromatosis type 1 protein. EMBO Rep. 7, 174-179
59. Bankaitis, V. A., Aitken, J. R., Cleves, A. E. and Dowhan, W. (1990) An essential role for a phospholipid transfer protein in yeast Golgi function. Nature 347, 561-562
60. Cleves, A., McGee, T. and Bankaitis, V. (1991) Phospholipid transfer proteins: a biological debut. Trends Cell Biol. 1, 30-34 (Pubitemid 121001658)
61. Kostenko, E. V., Mahon, G. M., Cheng, L. and Whitehead, I. P. (2005) The Sec14 homology domain regulates the cellular distribution and transforming activity of the Rho-specific guanine nucleotide exchange factor Dbs. J. Biol. Chem. 280, 2807-2817 (Pubitemid 40189388)
62. Welti, S., Fraterman, S., D'Angelo, I., Wilm, M. and Scheffzek, K. (2007) The sec14 homology module of neurofibromin binds cellular glycerophospholipids: mass spectrometry and structure of a lipid complex. J. Mol. Biol. 366, 551-562 (Pubitemid 46136212)
63. Blomberg, N., Baraldi, E., Nilges, M. and Saraste, M. (1999) The PH superfold: a structural scaffold for multiple functions. Trends Biochem. Sci. 24, 441-445 (Pubitemid 29528206)
64. Lemmon, M. A. (2004) Pleckstrin homology domains: not just for phosphoinositides. Biochem. Soc. Trans. 32, 707-711
65. Danglot, G., Regnier, V., Fauvet, D., Vassal, G., Kujas, M. and Bernheim, A. (1995) Neurofibromatosis 1 (NF1) mRNAs expressed in the central nervous system are differentially spliced in the 5′part of the gene. Hum. Mol. Genet. 4, 915-920
66. Gutman, D. H., Andersen, L. B., Cole, J. L., Swaroop, M. and Collins, F. S. (1993) An alternatively-spliced mRNA in the carboxy terminus of the neurofibromatosis type 1 (NF1) gene is expressed in muscle. Hum. Mol. Genet. 2, 989-992 (Pubitemid 23216632)
67. Andersen, L. B., Ballester, R., Marchuk, D. A., Chang, E., Gutmann, D. H., Saulino, A. M., Camonis, J., Wigler, M. and Collins, F. S. (1993) A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity. Mol. Cell. Biol. 13, 487-495 (Pubitemid 23006926)
68. Gutmann, D. H., Cole, J. L. and Collins, F. S. (1994) Modulation of neurofibromatosis type 1 gene expression during in vitro myoblast differentiation. J. Neurosci. Res. 37, 398-405 (Pubitemid 24072926)
69. Geist, R. T. and Gutmann, D. H. (1996) Expression of a developmentally-regulated neuron-specific isoform of the neurofibromatosis 1 (NF1) gene. Neurosci. Lett. 211, 85-88 (Pubitemid 26244682)
70. Skuse, G. R. and Cappione, A. J. (1997) RNA processing and clinical variability in neurofibromatosis type I (NF1). Hum. Mol. Genet. 6, 1707-1712 (Pubitemid 27401614)
71. Reference deleted
72. Mantani, A., Wakasugi, S., Yokota, Y., Abe, K., Ushio, Y. and Yamamura, K. (1994) A novel isoform of the neurofibromatosis type-1 mRNA and a switch of isoforms during murine cell differentiation and proliferation. Gene 148, 245-251 (Pubitemid 24333682)
73. Uchida, T., Matozaki, T., Suzuki, T., Matsuda, K., Wada, K., Nakano, O., Konda, Y., Nishisaki, H., Nagao, M., Sakamoto, C. et al. (1992) Expression of two types of neurofibromatosis type 1 gene transcripts in gastric cancers and comparison of GAP activities. Biochem. Biophys. Res. Commun. 187, 332-339
74. Costa, R. M., Yang, T., Huynh, D. P., Pulst, S. M., Viskochil, D. H., Silva, A. J. and Brannan, C. I. (2001) Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1. Nat. Genet. 27, 399-405 (Pubitemid 32268420)
75. Barron, V. A., Zhu, H., Hinman, M. N., Ladd, A. N. and Lou, H. (2010) The neurofibromatosis type I pre-mRNA is a novel target of CELF protein-mediated splicing regulation. Nucleic Acids Res. 38, 253-264
76. Zhu, H., Hinman, M. N., Hasman, R. A., Mehta, P. and Lou, H. (2008) Regulation of neuron-specific alternative splicing of neurofibromatosis type 1 pre-mRNA. Mol. Cell. Biol. 28, 1240-1251 (Pubitemid 351214127)
77. Chapple, J. P., Anthony, K., Martin, T. R., Dev, A., Cooper, T. A. and Gallo, J. M. (2007) Expression, localization and tau exon 10 splicing activity of the brain RNA-binding protein TNRC4. Hum. Mol. Genet. 16, 2760-2769 (Pubitemid 350018518)
78. Ladd, A. N., Charlet, N. and Cooper, T. A. (2001) The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol. Cell. Biol. 21, 1285-1296 (Pubitemid 32114976)
79. Ladd, A. N., Nguyen, N. H., Malhotra, K. and Cooper, T. A. (2004) CELF6, a member of the CELF family of RNA-binding proteins, regulates muscle-specific splicing enhancer-dependent alternative splicing. J. Biol. Chem. 279, 17756-17764 (Pubitemid 38560542)
80. Okano, H. J. and Darnell, R. B. (1997) A hierarchy of Hu RNA binding proteins in developing and adult neurons. J. Neurosci. 17, 3024-3037 (Pubitemid 27175816)
81. Hinman, M. N. and Lou, H. (2008) Diverse molecular functions of Hu proteins. Cell Mol. Life Sci. 65, 3168-3181
82. Izquierdo, J. M. (2010) Heterogeneous ribonucleoprotein C displays a repressor activity mediated by T-cell intracellular antigen-1-related/like protein to modulate Fas exon 6 splicing through a mechanism involving Hu antigen R. Nucleic Acids Res. 38, 8001-8014
83. Izquierdo, J. M. (2010) Cell-specific regulation of Fas exon 6 splicing mediated by Hu antigen R. Biochem. Biophys. Res. Commun. 402, 324-328
84. Izquierdo, J. M. (2008) Hu antigen R (HuR) functions as an alternative pre-mRNA splicing regulator of Fas apoptosis-promoting receptor on exon definition. J. Biol. Chem. 283, 19077-19084
85. Wang, H., Molfenter, J., Zhu, H. and Lou, H. (2010) Promotion of exon 6 inclusion in HuD pre-mRNA by Hu protein family members. Nucleic Acids Res. 38, 3760-3770
86. Bellavia, D., Mecarozzi, M., Campese, A. F., Grazioli, P., Talora, C., Frati, L., Gulino, A. and Screpanti, I. (2007) Notch3 and the Notch3-upregulated RNA-binding protein HuD regulate Ikaros alternative splicing. EMBO J. 26, 1670-1680 (Pubitemid 46480945)
87. Barreau, C., Paillard, L., Mereau, A. and Osborne, H. B. (2006) Mammalian CELF/Bruno-like RNA-binding proteins: molecular characteristics and biological functions. Biochimie 88, 515-525 (Pubitemid 43867902)
88. Faustino, N. A. and Cooper, T. A. (2005) Identification of putative new splicing targets for ETR-3 using sequences identified by systematic evolution of ligands by exponential enrichment. Mol. Cell. Biol. 25, 879-887 (Pubitemid 40165797)
89. Hawes, J. J., Tuskan, R. G. and Reilly, K. M. (2007) Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies. Neurogenetics 8, 121-130 (Pubitemid 46356250)
90. Costa, R. M., Federov, N. B., Kogan, J. H., Murphy, G. G., Stern, J., Ohno, M., Kucherlapati, R., Jacks, T. and Silva, A. J. (2002) Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature 415, 526-530 (Pubitemid 34130607)
91. Friedman, J. M., Arbiser, J., Epstein, J. A., Gutmann, D. H., Huot, S. J., Lin, A. E., McManus, B. and Korf, B. R. (2002) Cardiovascular disease in neurofibromatosis 1: report of the NF1 Cardiovascular Task Force. Genet. Med. 4, 105-111 (Pubitemid 44698568)
92. Rasmussen, S. A., Yang, Q. and Friedman, J. M. (2001) Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am. J. Hum. Genet. 68, 1110-1118 (Pubitemid 32424410)
93. Rosser, T. L., Vezina, G. and Packer, R. J. (2005) Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1. Neurology 64, 553-555 (Pubitemid 40189883)
94. Jacks, T., Shih, T. S., Schmitt, E. M., Bronson, R. T., Bernards, A. and Weinberg, R. A. (1994) Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat. Genet. 7, 353-361 (Pubitemid 24204410)
95. +/- mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathway. Hum. Mol. Genet. 17, 2336-2344
96. Lasater, E. A., Li, F., Bessler, W. K., Estes, M. L., Vemula, S., Hingtgen, C. M., Dinauer, M. C., Kapur, R., Conway, S. J. and Ingram, Jr, D. A. (2010) Genetic and cellular evidence of vascular inflammation in neurofibromin-deficient mice and humans. J. Clin. Invest. 120, 859-870
97. Li, F., Munchhof, A. M., White, H. A., Mead, L. E., Krier, T. R., Fenoglio, A., Chen, S., Wu, X., Cai, S., Yang, F. C. et al. (2006) Neurofibromin is a novel regulator of RAS-induced signals in primary VSMCs. Hum. Mol. Genet. 15, 1921-1930 (Pubitemid 43821782)